NeuroVive Pharmaceutical AB: Year-End Report 1 Jan. 2014 Till 31 Dec. 2014

Regulatory News:

NeuroVive (STO:NVP):

Fourth Quarter (1 Oct. 2014 – 31 Dec. 2014)

· Net revenues were SEK 0 (0) and other operating income was SEK 8,000 (12,000).

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC